Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram

Stroke

Volumn 25, Issue 6, 1994, Pages 1099-1104

  Andersen, Grethe ^a   Vestergaard, Karsten ^a   Lauritzen, Lise ^b  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b FREDERIKSBORG GENERAL HOSPITAL   (Denmark)

Author keywords

Antidepressive agents; Cerebrovascular disorders; Citalopram; Depression

Indexed keywords

CITALOPRAM; SEROTONIN; SEROTONIN RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STROKE;

ADULT; AGED; AGED, 80 AND OVER; CEREBROVASCULAR DISORDERS; CITALOPRAM; COHORT STUDIES; DEPRESSION; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NAUSEA; PLACEBOS; TREATMENT OUTCOME; VOMITING;

EID: 0028232860     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.25.6.1099     Document Type: Article

References (38)

1. Folstein MF, Maiberger R, McHugh PR. Mood disorder as a specific complication of stroke. J Neurol Neurosurg Psychiatry. 1977;40:1018-1020.
2. Robinson RG, Price TR. Post-stroke depressive disorders: a follow-up study of 103 patients. Stroke. 1982;13:635-640.
3. Robinson RG, Starr LB, Kubos KL, Price TR. A two-year longitudinal study of post-stroke mood disorders: findings during the initial evaluation. Stroke. 1983;14:736-741.
4. Robinson RG, Bolduc PL, Price TR. Two-year longitudinal study of poststroke mood disorders: diagnosis and outcome at one and two years. Stroke. 1987;18:837-843.
5. Sinyor D, Amato P, Kalouped DG, Becker R, Goldenberg M, Coopersmith H. Post-stroke depression: relationships to functional impairment, coping strategies, and rehabilitation outcome. Stroke. 1986;17:1102-1107.
6. Wade DT, Legh-Smith J, Hewer RA. Depressed mood after stroke: a community study of its frequency. Br J Psychiatry. 1987; 151:200-205.
7. Eastwood MR, Rifat SL, Nobbs H, Ruderman J. Mood disorder following cerebrovascular accident. Br J Psychiatry. 1989;154: 195-200.
8. Dam H, Pedersen HE, Ahlgren P. Depression among patients with stroke. Acta Psychiatr Scand. 1989;80:118-124.
9. Morris PLP, Robinson RG, Raphael B. Prevalence and course of depressive disorders in hospitalized stroke patients. Int J Psychiatry Med. 1990;20:349-364.
10. Sharpe M, Hawton K, House A, Molyneux A, Sandercock P, Bamford J, Warlow C. Mood disorders in long-term survivors of stroke: associations with brain lesion location and volume. Psychol Med. 1990;20:815-828.
11. House A, Dennis M, Mogridge L, Warlow C, Hawton K, Jones L. Mood disorders in the year after first stroke. Br J Psychiatry. 1991;158:83-92.
12. Robins AH. Are stroke patients more depressed than other disabled subjects? J Chronic Dis. 1976;29:479-482.
13. Charatan FB, Fisk A. Mental and emotional results of strokes. N Y State J Med. 1978;78:1403-1405.
14. Turner RJ, Beiser M. Major depression and depressive symptomatology among the physically disabled: assessing the role of chronic stress. J Nerv Ment Dis. 1990;178:343-350.
15. Reding MJ, Orto LA, Winter SW, Fortuna IM, Di Ponte P, McDowell FH. Antidepressant therapy after stroke. Arch Neurol. 1986;43:763-765.
16. Lipsey JR, Robinson RG, Pearlson GD, Rao K, Price TR. Nortriptyline treatment of post-stroke depression: a double-blind study. Lancet. 1984;1:297-300.
17. Fullerton AG. Side-effects of nortriptyline treatment for poststroke depression. Lancet. 1984;1:519. Letter.
18. Agerholm M. Side-effects of nortriptyline treatment for poststroke depression. Lancet. 1984; 1:519. Letter.
19. Over0 KF, Toft B, Christophersen L, Gylding-Sabroe JP. Kinetics of citalopram in elderly patients. Psychopharmacology. 1985;86: 253-257.
20. Bech P. Acute therapy of depression. J Clin Psychiatry. 1993; 54(suppl 8):18-27.
21. Lauritzen L, Bjerg Bendsen B, Vilmar T, Bjerg Bendsen E, Lunde M, Bech P. Post-stroke depression: combined treatment with imip- ramine or desipramine and mianserin: a controlled clinical study. Psychopharmacology. 1994;114:119-122.
22. Sheikh K, Smith DS, Meade TW, Brennan PJ, Ide L. Assessment of motor function in studies of chronic disability. Rheumatol Rehabil. 1980;19:83-90.
23. Goodglass H, Kaplan E. The Assessment of Aphasia and Related Disorders. Philadelphia, Pa: Lea & Febiger; 1983.
24. Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. Md State Med J. 1965;14:61-65.
25. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. In: Bellak L, Karasu TH, eds. Geriatric Psychiatry: A Handbook for Psychiatrists and Primary Care Physicians. New York, NY: Grune & Stratton, Inc; 1976:77-121.
26. Folstein MF, Folstein SE, McHugh PR. ‘Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
27. Holbrook M, Skilbeck CE. An activities index for use with stroke patients. Age Ageing. 1983;12:166-170.
28. Bech P, Kastrup M, Rafaelsen OJ. Mini-compendium of rating scales for states of anxiety, depression, mania, schizophrenia with corresponding DSM-III syndromes. Acta Psychiatr Scand. 1986; 73(suppl 326):7-37.
29. Beck P. Rating scales for mood disorders: applicability, consistency and construct validity. Acta Psychiatr Scand. 1988;78(suppl 345): 45-55.
30. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed, revised. Washington, DC: American Psychiatric Association; 1987.
31. Paykel ES. Use of the Hamilton Depression Scale in general practice. In: Bech P, Coppen A, eds. The Hamilton Scales. Berlin, Germany: Springer-Verlag; 1990:40-47.
32. Lingjærde O, Ahlfors UG, Bech P, Dencker SJ, Elgren K. The UKU side effect rating scale. Acta Psychiatr Scand. 1987;76(suppl 334):l-99.
33. Carney MWP, Roth M, Garside RF. The diagnosis of depressive syndromes and the prediction of ECT response. Br J Psychiatry. 1965;111:659-674.
34. Danish University Antidepressant Group (DUAG). Paroxetine: a selective serotonin reuptake inhibitor showing better tolerance but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord. 1990;18:280-299.
35. Stegmayr B, Asplund K. Measuring stroke in the population: quality of routine statistics in comparison with a population-based stroke registry. Neuroepidemiology. 1992;11:204-213.
36. Prescott RJ, Coarraway WM, Akhtar AJ. Predicting functional outcome following acute stroke using a standard clinical examination. Stroke. 1982;13:641-647.
37. Skilbeck CE, Wade DT, Langton-Hewer R, Wood VA. Recovery after stroke. J Neurol Neurosurg Psychiatry. 1983;46:5-8.
38. Kaplan HI, Sadock BJ. Modern Synopsis of Comprehensive Textbook of Psychiatry. 4th ed. Baltimore, Md: Williams & Wilkins Co; 1985:623-626.